LINCOLN
Invest Now
Start SIP in
LINCOLN
Performance
- Low
- ₹545
- High
- ₹553
- 52 Week Low
- ₹499
- 52 Week High
- ₹980
- Open Price₹550
- Previous Close₹550
- Volume18,164
Investment Returns
- Over 1 Month -6.25%
- Over 3 Month -0.6%
- Over 6 Month -28.46%
- Over 1 Year -15.34%
Smart Investing Starts Here Start SIP with Lincoln Pharmaceuticals for Steady Growth!
Lincoln Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 13.3
- PEG Ratio
- -1.1
- Market Cap Cr
- 1,093
- P/B Ratio
- 1.7
- Average True Range
- 14.25
- EPS
- 41.11
- Dividend Yield
- 0.3
- MACD Signal
- -2.04
- RSI
- 39.31
- MFI
- 49.5
Lincoln Pharmaceuticals Financials
Lincoln Pharmaceuticals Technicals
EMA & SMA
Current Price
₹545.70
-4.15
(-0.75%)

-
- Bearish Moving Average 16
-
- Bullish Moving Average 0
- 20 Day
- ₹563.33
- 50 Day
- ₹569.08
- 100 Day
- ₹588.73
- 200 Day
- ₹614.49
Resistance and Support
553.15
- R3 569.95
- R2 565.45
- R1 557.65
- S1 545.35
- S2 540.85
- S3 533.05
Lincoln Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-22 | Audited Results & Final Dividend | |
2025-02-13 | Quarterly Results | |
2024-11-14 | Quarterly Results | |
2024-08-08 | Quarterly Results | |
2024-05-16 | Audited Results & Final Dividend |
Lincoln Pharmaceuticals F&O
About Lincoln Pharmaceuticals
- NSE Symbol
- LINCOLN
- BSE Symbol
- 531633
- Managing Director
- Mr. Mahendra G Patel
- ISIN
- INE405C01035
Similar Stocks to Lincoln Pharmaceuticals
Lincoln Pharmaceuticals FAQs
Lincoln Pharmaceuticals share price is ₹545 As on 14 July, 2025 | 11:28
The Market Cap of Lincoln Pharmaceuticals is ₹1093 Cr As on 14 July, 2025 | 11:28
The P/E ratio of Lincoln Pharmaceuticals is 13.3 As on 14 July, 2025 | 11:28
The PB ratio of Lincoln Pharmaceuticals is 1.7 As on 14 July, 2025 | 11:28
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.